Synapse - Works

Results (180)

Impact of reactive changes on multigene testing: Histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores

Journal Article

Grabenstetter, A.; Brogi, E.; Thompson, D. M.; Blinder, V. S.; Norton, L.; Morrow, M.; Robson, M. E.; Wen, H. Y.
Breast Cancer Research and Treatment (2024)

Fulltext@MSK | Save

Prognostic implications of HER2 gain in patients with HR+/ HER2-breast cancer (BC) and TNBC after neoadjuvant chemotherapy (NAC)

Meeting Abstract

Ferraro, E.; Chew Minmin, S.; Nemirovsky, D.; Chen, Y.; Barrio, A. V.; Modi, S.; Seidman, A.; Wen, H.; Brogi, E.; Robson, M.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Mutational status is associated with a higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer

Journal Article

Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
Annals of Surgical Oncology (2023)

Fulltext@MSK | Save

Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: What do we tell patients?

Editorial

Lee, M. K.; Robson, M. E.
JNCI: Journal of the National Cancer Institute (2023)

Fulltext@MSK | Save

Biospecimen repositories in low- and middle-income countries: Insights from an American University of Beirut and Memorial Sloan Kettering collaboration

Journal Article

Faraj, W.; Robson, M.; Tawil, A.; Reuter, V.; Mahfouz, R.; Cambria, R.; Saheb, N.; Ferrer, C. S.; Vemuri, S.; Yaghi, M.; more...
JCO Global Oncology (2023)

Fulltext@MSK | Save

ASO Visual Abstract: Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease

Miscellaneous

Zhang, J. Q.; Dos Anjos, C. H.; Sevilimedu, V.; Crown, A.; Amoroso, K. A.; Pilewskie, M. L.; Robson, M. E.; Gemignani, M. L.
Annals of Surgical Oncology (2023)

Fulltext@MSK | Save

ASO Visual Abstract: Mutational status is associated with higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer

Miscellaneous

Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
Annals of Surgical Oncology (2023)

Fulltext@MSK | Save

Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease

Journal Article

Zhang, J. Q.; Dos Anjos, C. H.; Sevilimedu, V.; Crown, A.; Amoroso, K. A.; Pilewskie, M. L.; Robson, M. E.; Gemignani, M. L.
Annals of Surgical Oncology (2023)

Fulltext@MSK | Save

BRCA mutational status is associated with higher rate of pathologic complete response in hormone receptor-positive breast cancer

Meeting Abstract

Myers, S. P.; Walsh, E. M.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
Annals of Surgical Oncology (2023)

Fulltext@MSK | Save

Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab

Meeting Abstract

Chew, S.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D. W.; Modi, S.; Seidman, A. D.; Wen, H. Y.; Brogi, E.; Robson, M. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save